PGEN Precigen Inc

Price (delayed)

$3.85

Market cap

$1.37B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.18

Enterprise value

$1.46B

?
Relative Growth: Rel. Growth: 40
Relative Strength: Rel. Strength: 81
Relative Valuation: Rel. Valuation: 5
Relative Profitability: Rel. Profitability: 18

Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases ...

Highlights
PGEN's gross margin has soared by 60% from the previous quarter
PGEN's quick ratio is up by 43% from the previous quarter and by 16% YoY
Precigen's EPS has shrunk by 111% YoY but it has increased by 14% QoQ
PGEN's net income is down by 30% year-on-year but it is up by 18% since the previous quarter
PGEN's equity is down by 3.2% since the previous quarter

Key stats

What are the main financial stats of PGEN

PGEN stock price

How has the Precigen stock price performed over time
Intraday
1.05%
1 week
-14.63%
1 month
-7%
1 year
189.47%
YTD
-7.89%
QTD
-0.52%

Financial performance

How have Precigen's revenue and profit performed over time
Revenue
$31.6M
Gross profit
$25.31M
Operating income
-$93.91M
Net income
-$204.42M
Gross margin
80.1%
Net margin
-647%
PGEN's operating margin has soared by 91% YoY and by 74% from the previous quarter
Precigen's net margin has soared by 83% YoY and by 75% from the previous quarter
PGEN's gross margin has soared by 60% from the previous quarter
Precigen's operating income has increased by 30% YoY and by 15% from the previous quarter

Price vs fundamentals

How does PGEN's price correlate with its fundamentals

Growth

What is Precigen's growth rate over time

Valuation

What is Precigen stock price valuation
P/E
N/A
P/B
67.34
P/S
43.17
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
46.32
Precigen's EPS has shrunk by 111% YoY but it has increased by 14% QoQ
PGEN's equity is down by 3.2% since the previous quarter
PGEN's P/S is 97% below its 5-year quarterly average of 1276.9 and 61% below its last 4 quarters average of 108.9

Efficiency

How efficient is Precigen business performance
The ROA has plunged by 86% YoY but it has grown by 12% from the previous quarter
Precigen's return on sales has surged by 83% YoY and by 75% QoQ
PGEN's return on equity has surged by 77% since the previous quarter
The ROIC has soared by 62% YoY and by 34% from the previous quarter

Dividends

What is PGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGEN.

Financial health

How did Precigen financials performed over time
The company's total assets is 17% higher than its total liabilities
PGEN's current ratio has surged by 56% since the previous quarter and by 37% year-on-year
PGEN's quick ratio is up by 43% from the previous quarter and by 16% YoY
PGEN's debt to equity is up by 3.4% from the previous quarter
PGEN's equity is down by 3.2% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.